2. Academic Validation
  3. MTCH2 regulates NRF2-mediated RRM1 expression to promote melanoma proliferation and dacarbazine insensitivity

MTCH2 regulates NRF2-mediated RRM1 expression to promote melanoma proliferation and dacarbazine insensitivity

  • Cell Death Dis. 2025 Apr 9;16(1):268. doi: 10.1038/s41419-025-07618-9.
Xuedan Zhang # 1,  Enjiang Li # 1,  Yingmin Kuang # 2,  Yanlong Gai 1,  Yu Feng 1,  Yu Huang 1,  Zhenyan Wei 1,  Junzi Niu 1,  Song Yu 1,  Zhe Yang 3,  Qiao Zhang 1,  Buqing Sai 4,  Yuechun Zhu 5
Affiliations

Affiliations

  • 1 Department of Biochemistry and Molecular Biology, School of Basic Medicine, Kunming Medical University, Kunming, 650500, Yunnan, China.
  • 2 Department of Organ Transplantation, First Affiliated Hospital of Kunming Medical University, Kunming, 650500, Yunnan, China.
  • 3 Department of Pathology, First Affiliated Hospital of Kunming Medical University, Kunming, 650500, Yunnan, China.
  • 4 Department of Biochemistry and Molecular Biology, School of Basic Medicine, Kunming Medical University, Kunming, 650500, Yunnan, China. saibuqing@kmmu.edu.cn.
  • 5 Department of Biochemistry and Molecular Biology, School of Basic Medicine, Kunming Medical University, Kunming, 650500, Yunnan, China. zhuyuechun@kmmu.edu.cn.
  • # Contributed equally.
PMID: 40204724 DOI: 10.1038/s41419-025-07618-9
Abstract

Melanoma is among the 10 most prevalent malignant tumors, posing a significant threat to human health. A detailed understanding of the molecular mechanisms driving its progression is crucial for advancing treatment strategies and outcomes. Based on bioinformatic analysis and experimental validation, this study identified mitochondrial carrier homolog 2 (MTCH2) as a key regulator of melanoma proliferation. Mechanistically, MTCH2 enhanced the expression and nuclear translocation of nuclear factor (erythroid-derived-2)-like 2 (NRF2), which up-regulated ribonucleotide reductase subunit M1 (RRM1) expression, thereby promoting melanoma cell proliferation. Targeting RRM1 in combination with dacarbazine significantly inhibited tumor growth in nude mouse xenograft models. These findings elucidate a mechanistic link between MTCH2 and the NRF2-RRM1 axis in melanoma proliferation and highlight potential therapeutic targets for intervention.

Figures
Products